Robert L. Lewis
President, IHL Consulting Group, Inc.

Robert has been a consultant to the pharmaceutical industry since September, 2000, when he founded IHL Consulting Group, Inc.  IHL is committed to addressing the compliance needs of FDA regulated industry by providing outstanding service with a pragmatic approach.  As a consultant, Robert has performed quality system assessments, Pre-Approval readiness evaluations, and vendor audits to determine conformance with FDA expectations.  Robert is often a guest speaker at industry seminars, meetings and conferences addressing regulatory compliance issues.

In his previous position with the US Food and Drug Administration as an Investigator / Drug Specialist for ten years (1990-2000), Robert conducted numerous cGMP and NDA / ANDA pre-approval inspections at major domestic and international pharmaceutical facilities of multiple dosage forms, was Co-Leader of Atlanta District Drug Team, and the Assistant ANDA / NDA Pre-Approval Program Manager.  Robert holds a Bachelor of Science in Applied Biology from Georgia Tech.